Investing in small-cap health care companies can be tricky, with stocks that can soar or crash based on the results of a single clinical trial. However, equities.com's Small-Cap Stars, our proprietary list of small-cap companies with characteristics we've found to be most predictive of future success, isolates those companies that are best positioned to succeed.
Here are today's top performing health care Small-Cap Stars:
Arrowhead Research Corp (ARWR)
Arrowhead Research Corp gained 13.08% to $15.20. The gains came on a volume of 8,904,870 shares against an average daily volume of 3,129,431 shares. Arrowhead Research Corp has had a trading range from $27.63 to $4.08 over the last year, it has a 50-day SMA of $12.85, and a 200-day SMA of $13.48.
Arrowhead Research Corp is a biopharmaceutical company developing targeted RNAi therapeutics.
Erba Diagnostics (ERB)
Erba Diagnostics gained 11.64% to $3.55. The gains came on a volume of 333,592 shares against an average daily volume of 71,616 shares. Erba Diagnostics has had a trading range from $4.13 to $0.77 over the last year, its P/E ratio is 131.5, it has a 50-day SMA of $2.27, and a 200-day SMA of $2.33.
ERBA Diagnostics Inc develop, manufacture and market diagnostic test kits, and instrumentation in the areas of autoimmune, chemistry, hematology, diabetes and infectious diseases.
Galena Biopharma Inc. (GALE)
Galena Biopharma Inc. gained 11.43% to $2.34. The gains came on a volume of 3,542,900 shares against an average daily volume of 2,248,385 shares. Galena Biopharma Inc. has had a trading range from $7.77 to $1.66 over the last year, it has a 50-day SMA of $2.84, and a 200-day SMA of $3.37.
Galena Biopharma Inc, is a biopharmaceutical company focused on developing and commercializing, targeted treatments that address unmet medical needs to advance cancer care.
Idera Pharmaceuticals Inc. (IDRA)
Idera Pharmaceuticals Inc. gained 9.43% to $2.90. The gains came on a volume of 1,686,760 shares against an average daily volume of 978,801 shares. Idera Pharmaceuticals Inc. has had a trading range from $6.87 to $1.52 over the last year, it has a 50-day SMA of $2.76, and a 200-day SMA of $3.50.
Idera Pharmaceuticals, Inc. is a clinical stage biotechnology company engaged in the discovery and development of novel synthetic DNA- and RNA- based drug candidates.
Zogenix Inc. (ZGNX)
Zogenix Inc. gained 9.39% to $1.34. The gains came on a volume of 3,836,250 shares against an average daily volume of 1,783,223 shares. Zogenix Inc. has had a trading range from $5.19 to $1.18 over the last year, it has a 50-day SMA of $1.62, and a 200-day SMA of $2.82.
Zogenix Inc is a pharmaceutical company engaged in commercializing & developing therapies that address clinical needs for people living with pain-related and CNS disorders that needs treatment alternatives to help return to normal daily functioning.
Equities.com's Health Care Small-Cap Stars - Helping You Build a Healthier Portfolio
No one can predict precisely which potential treatments will fly through their clinical trials and which will stumble along the way. At least, if someone can, they're undoubtedly spectacularly wealthy right now. But, while the science is clearly the most important factor for the success of a small-cap biotech company, it's not the only one.
Equities.com's Small-Cap Stars system uses a complicated statistical regression to determine which fundamental factors previous success stories had in common and then identifies those present health care small caps that share those traits. For health care companies, we found that a high enterprise value, a strong value line beta, and a high rate of reinvestment were among the most important qualities in predicting the potential success of a company.
All data provided by QuoteMedia and was accurate as of 4:30 pm ET.